Financials
Halo Pharm, LLC: Comprehensive Financial Plan and Investment Summary
1. Executive Summary
Halo Pharm, LLC aims to establish a strong foothold in the Alaska cannabis market by launching a scalable, high-tech cultivation and extraction operation. With an initial investment of $1,900,000, the company will start with a smaller-scale operation, focusing on two grow rooms, essential equipment, and partial automation. The phased growth plan is designed to optimize costs, minimize risk, and gradually scale operations by reinvesting profits into expanding grow rooms, increasing production, and diversifying product offerings.
2. Articles of Incorporation
• Company Name: Halo Pharm, LLC
• Principal Office: 53270 St. Elias Avenue, Kasilof, Alaska 99610
• Registered Agent: Jeanne Harlow Maltby, 53270 St. Elias Avenue, Kasilof, Alaska 99610
• Incorporators: Van C. Adams, Jeanne Harlow Maltby, 53270 St. Elias Avenue, Suite #1, Kasilof, Alaska
• Purpose: Fully Integrated Cannabis Corporation: Cultivation, Extraction, and Retail/Dispensary
• Duration: Perpetual
• Number of Shares Authorized: 10,000,000 Shares
• Initial Directors: Rose Marie McKenzie, Jane O'Leary, Jeanne Harlow Maltby, Van Adams
• Par Value of Shares: $0.95/share
3. Operating Agreement
• Owner: Van C. Adams (100% ownership initially)
• Management Structure: Manager-managed
• Capital Contributions: Initial capital from investments
• Profit and Loss Allocation: Based on ownership percentages (initially 100% to Van C. Adams)
• Voting Rights: As per Shareholder Agreement and Bylaws
• Meetings: As per Bylaws
• Banking and Financial Records: Maintained through an outsourced CFO/Accountant
• Transfer of Membership Interests: As per Bylaws and Shareholder Agreement
• Non-Compete and Confidentiality Agreements: As per Bylaws and Shareholder Agreement
4. Shareholder Agreement
• Share Structure:
◦ Class A shares: 10 votes per share, held by Founders and founder-appointed board members
◦ Class B shares: 1 vote per share, held by other shareholders
• Voting Rights:
◦ Founder Voting Rights: Founder has a deciding vote or veto power on strategic matters.
◦ Supermajority Voting: Requires 51% approval, including founder-appointed directors' affirmative vote.
• Drag-Along and Tag-Along Rights:
◦ Drag-Along: Majority Class A shareholders can compel other shareholders to sell their shares under the same terms.
◦ Tag-Along: Minority shareholders can sell their shares under the same terms as majority shareholders.
• Preemptive Rights: Existing shareholders have the right to purchase new shares before they are offered to new investors.
5. Initial Funding Requirements
• Total Initial Funding Needed: $1,900,000
• Use of Funds: Initial setup includes 2 grow rooms, essential equipment, and partial automation.
Breakdown of Initial Investment:
◦ Land: $162,500
◦ Modular Steel Building: $500,000
◦ LED Grow Lights: $200,000
◦ Automated Climate Controls: $50,000
◦ Automated Watering/Fertigation Systems: $75,000
◦ Steel Security Fencing: $50,000
◦ Comprehensive Security System: $50,000
◦ Solar Panels: $100,000
◦ Rooftop Wind Turbines: $50,000
◦ Large Capacity Trimming Machine: $25,000
◦ Vacuum Seal Machine: $2,000
◦ Nutrients, Soil, Pots: $30,000
◦ Other Equipment: $20,000
◦ Used Truck: $25,000
◦ Founder Salary: $55,000
◦ Outsourced CFO/Accountant: $60,000
◦ Outsourced Attorney: $30,000
◦ Marketing: $20,000
Total Initial Investment: $1,474,500
6. Phased Expansion Strategy
• Phase 1: Initial setup (2 grow rooms) – $1,474,500
• Phase 2: Expand to 4 grow rooms – Estimated additional $750,000
• Phase 3: Expand to 6 grow rooms and full automation – Estimated additional $750,000
The strategy involves reinvesting profits from the initial operation to fund these expansions, thereby reducing the need for further external funding and minimizing investor dilution.
7. Cash Flow Statement
For the First Year:
• Operating Activities:
◦ Cash Receipts from Sales: $36,600,000
◦ Cash Payments to Suppliers and Employees: $13,126,792
◦ Cash Paid for Operating Expenses: $513,168.10
• Investing Activities:
◦ Cash Payments for Capital Expenditures: $1,474,500
• Financing Activities:
◦ Cash Receipts from Issuing Equity or Debt: $1,900,000
Ending Cash Balance:
◦ Initial Cash Balance: $100,000
◦ Net Cash Provided by Operating Activities: $22,960,039.90
◦ Net Cash Used in Investing Activities: $1,474,500
◦ Net Cash Provided by Financing Activities: $1,900,000
◦ Total Ending Cash Balance: $23,485,539.90
8. Break-Even Analysis
• Fixed Costs: $988,210.10
• Variable Costs per Unit: $4,880
• Break-Even Point: Adjust realistic growth costs for accurate breakeven analysis.
9. Budget Plan
Annual Budget (Year 1 - 2024):
• Revenue: $36,600,000
• COGS: $12,810,000
• Operating Expenses: $829,960.10
• Other Expenses: $1,830,000
• Taxes: $5,282,509.975
• Net Income: $15,847,529.925
Quarterly Budgets (2024):
• Each quarter reflects revenue of $9,150,000, operating expenses of $207,490.025, and net income of $3,961,882.485.
10. Financial Projections
Revenue Projections (Next 3-5 Years):
• Year 1 (2024): $36,600,000
• Year 2 (2025): $50,000,000
• Year 3 (2026): $70,000,000
• Year 4 (2027): $100,000,000
• Year 5 (2028): $120,000,000
Expense Projections (Next 3-5 Years):
• Year 1 (2024): $524,449.88
• Year 2 (2025): $786,674.82
• Year 3 (2026): $866,342.30
• Year 4 (2027): $953,976.53
• Year 5 (2028): $1,049,374.18
Capital Expenditures (Next 3-5 Years):
• Year 1 (2024): $1,474,500
• Year 2 (2025): $750,000
• Year 3 (2026): $750,000
Funding Requirements:
• Initial Funding (Year 1): $1,900,000
• Subsequent Rounds (Years 2-5): $1,500,000
Conclusion
Halo Pharm, LLC is positioned to become a key player in the Alaskan cannabis industry by leveraging a phased growth plan that minimizes risk, controls costs, and enables scalable expansion. The company’s strong financial planning, combined with a commitment to high-quality production and automation, ensures a solid return on investment for its stakeholders.